Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - CALADRIUS BIOSCIENCES, INC.Financial_Report.xls
10-Q - FORM 10-Q - CALADRIUS BIOSCIENCES, INC.v311330_10q.htm
EX-31.1 - EXHIBIT 31.1 - CALADRIUS BIOSCIENCES, INC.v311330_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - CALADRIUS BIOSCIENCES, INC.v311330_ex31-2.htm
EX-32.2 - EXHIBIT 32.2 - CALADRIUS BIOSCIENCES, INC.v311330_ex32-2.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of NeoStem, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2012 filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robin Smith, M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that:

 

(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended; and

 

(2)   The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of the dates presented and the results of operations of the Company for the periods presented.

 

Dated:  May 11, 2012

 

  /s/ Robin Smith, M.D.
  Robin Smith, M.D.
  Chief Executive Officer

 

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.

 

A signed original of this written statement required by Section 906 has been provided to NeoStem, Inc. and will be retained by NeoStem, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.